In early January 2014, a 46-year-old woman with myelodysplastic syndrome had a visit with her heme/onc physician.
Her past medical history included Crohn’s disease and she was on chronic total parenteral nutrition (TPN) following numerous small bowel resections.
The patient was taking filgrastim and erythropoietin among other medications.
At the visit she …